e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High short-term mortality following lung biopsy for usual interstitial pneumonia
Utz J.P., Ryu J.H., Douglas W.W., Hartman T.E., Tazelaar H.D., Myers J.L., Allen M.S., Schroeder D.R.
Source:
Eur Respir J 2001; 17: 175-179
Journal Issue:
February
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Utz J.P., Ryu J.H., Douglas W.W., Hartman T.E., Tazelaar H.D., Myers J.L., Allen M.S., Schroeder D.R.. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 2001; 17: 175-179
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Histopathological assessment and classification
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006
Clinical categorisation of idiopathic interstitial pneumonia
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Histology and pathogenesis of usual interstitial pneumonia (UIP)
versus
nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006
Idiopathic pulmonary fibrosis - IPF
Source: Respipedia Article
Year: 2018
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
Respiratory bronchiolitis-associated interstitial lung disease - RB-ILD
Source: Respipedia Article
Year: 2016
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
Quantifying risk of mortality in idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 149s
Year: 2001
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J 2009; 33: 68-76
Year: 2009
Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006
Idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia should stay separate
Source: Eur Respir J 2008; 31: 1141-1142
Year: 2008
Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality
Source: Eur Respir J 2010; 35: 1303-1311
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept